Dr. Reddy's, fighting to recover from FDA warning letter, recalls 500K heartburn tablets

20th October 2017 Uncategorised 0

Still struggling to turn its manufacturing around, Dr. Reddy’s is recalling 569,000 store-brand famotidine tablets in the U.S., thanks to failed tests for impurities and degradation. It’s the India-based company’s second recall of the same medication since last July.

More: Dr. Reddy's, fighting to recover from FDA warning letter, recalls 500K heartburn tablets
Source: fierce